MarketWatch.com - MarketPulse

Biogen’s soft guidance and a decline in sales at MS portfolio weigh

Feb 12, 2025 - 13:08
 0
Read More

Tags:

Previous Article

Nvidia Stock Is Doing Something It's Only Done Twice Before in the Past 4 Years....

Next Article

New rules mean big extra costs for car buyers

Related Posts

Coca-Cola’s stock jumps after a big sales beat, as case...

Feb 11, 2025  0

Trainline boosts guidance for the second time this year

Feb 9, 2025  0

Plus500 says it will meet expectations after quarterly ...

Feb 9, 2025  0